These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19580720)

  • 1. Aortic stenosis: look globally, think globally.
    Pibarot P; Dumesnil JG
    JACC Cardiovasc Imaging; 2009 Apr; 2(4):400-3. PubMed ID: 19580720
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy.
    Cramariuc D; Cioffi G; Rieck AE; Devereux RB; Staal EM; Ray S; Wachtell K; Gerdts E
    JACC Cardiovasc Imaging; 2009 Apr; 2(4):390-9. PubMed ID: 19580719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of statins in aortic valve disease.
    Rajamannan NM
    Heart Fail Clin; 2006 Oct; 2(4):395-413. PubMed ID: 17448427
    [No Abstract]   [Full Text] [Related]  

  • 4. Aortic valve stenosis and lipid-lowering therapy: the state of the art.
    Bonadei I; Vizzardi E; D'aloia A; Gelsomino S; De Cicco G; Lorusso R; Dei Cas L
    Panminerva Med; 2013 Dec; 55(4):391-5. PubMed ID: 24434347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.
    Rossebø AB; Pedersen TR; Allen C; Boman K; Chambers J; Egstrup K; Gerdts E; Gohlke-Bärwolf C; Holme I; Kesäniemi VA; Malbecq W; Nienaber C; Ray S; Skjaerpe T; Wachtell K; Willenheimer R
    Am J Cardiol; 2007 Apr; 99(7):970-3. PubMed ID: 17398194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pressure recovery on echocardiographic assessment of asymptomatic aortic stenosis: a SEAS substudy.
    Bahlmann E; Cramariuc D; Gerdts E; Gohlke-Baerwolf C; Nienaber CA; Eriksen E; Wachtell K; Chambers J; Kuck KH; Ray S
    JACC Cardiovasc Imaging; 2010 Jun; 3(6):555-62. PubMed ID: 20541709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.
    Holme I; Boman K; Brudi P; Egstrup K; Gohlke-Baerwolf C; Kesäniemi YA; Malbecq W; Rossebø AB; Wachtell K; Willenheimer R; Pedersen TR
    Am J Cardiol; 2010 Jun; 105(12):1802-8. PubMed ID: 20538134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy).
    Lund BP; Gohlke-Bärwolf C; Cramariuc D; Rossebø AB; Rieck AE; Gerdts E
    Am J Cardiol; 2010 May; 105(10):1456-60. PubMed ID: 20451694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcific aortic stenosis--time to look more closely at the valve.
    Otto CM
    N Engl J Med; 2008 Sep; 359(13):1395-8. PubMed ID: 18815402
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study).
    Gerdts E; Rossebø AB; Pedersen TR; Boman K; Brudi P; Chambers JB; Egstrup K; Gohlke-Bärwolf C; Holme I; Kesäniemi YA; Malbecq W; Nienaber C; Ray S; Skjærpe T; Wachtell K; Willenheimer R
    Am J Cardiol; 2010 Dec; 106(11):1634-9. PubMed ID: 21094366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic stenosis and lipids: does intervention work?
    Wierzbicki AS; Viljoen A; Chambers JB
    Curr Opin Cardiol; 2010 Jul; 25(4):379-84. PubMed ID: 20414108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcific aortic stenosis.
    Pazianas M
    N Engl J Med; 2009 Jan; 360(1):85; author reply 85-6. PubMed ID: 19118311
    [No Abstract]   [Full Text] [Related]  

  • 13. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
    Rossebø AB; Pedersen TR; Boman K; Brudi P; Chambers JB; Egstrup K; Gerdts E; Gohlke-Bärwolf C; Holme I; Kesäniemi YA; Malbecq W; Nienaber CA; Ray S; Skjaerpe T; Wachtell K; Willenheimer R;
    N Engl J Med; 2008 Sep; 359(13):1343-56. PubMed ID: 18765433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trileaflet aortic valve commissural fusion: a rare cause of aortic valve disease and systolic ejection sounds.
    Briasoulis A; Shaun C; Rashed A; Siddiqui F; Sharma S; Afonso L
    Int J Cardiovasc Imaging; 2014 Oct; 30(7):1265-6. PubMed ID: 24899220
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study.
    Gohlke-Bärwolf C; Minners J; Jander N; Gerdts E; Wachtell K; Ray S; Pedersen TR
    Curr Probl Cardiol; 2013 Sep; 38(9):365-409. PubMed ID: 23972937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction.
    Jander N; Minners J; Holme I; Gerdts E; Boman K; Brudi P; Chambers JB; Egstrup K; Kesäniemi YA; Malbecq W; Nienaber CA; Ray S; Rossebø A; Pedersen TR; Skjærpe T; Willenheimer R; Wachtell K; Neumann FJ; Gohlke-Bärwolf C
    Circulation; 2011 Mar; 123(8):887-95. PubMed ID: 21321152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of Outcome in Patients With Left Ventricular Impairment and Moderate Aortic Stenosis.
    Hayward C; Thornton G; Asher A; Tyebally S; Ray-Chaudhuri A; Mangan C; Mouyis K; Harvey G; Saheecha S; Liu S; Singhal A; Karia N; Patel K; Lloyd G; Bhattacharyya S
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1449-1450. PubMed ID: 32199839
    [No Abstract]   [Full Text] [Related]  

  • 19. Sex Differences in the Progression of Aortic Stenosis and Prognostic Implication: The COFRASA-GENERAC Study.
    Nguyen V; Mathieu T; Melissopoulou M; Cimadevilla C; Codogno I; Huart V; Duval X; Vahanian A; Messika-Zeitoun D
    JACC Cardiovasc Imaging; 2016 Apr; 9(4):499-501. PubMed ID: 27056168
    [No Abstract]   [Full Text] [Related]  

  • 20. Controversies surround heart drug study: questions about Vytorin and trial sponsors' conduct.
    Mitka M
    JAMA; 2008 Feb; 299(8):885-7. PubMed ID: 18314425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.